The European Union has signed an agreement with the American biotechnology company Modern to receive a supply of 160 million doses of its candidate for vaccine against covid-19, said the head of the European Commission on Tuesday.
Last week, Moderna said its experimental vaccine is 94.5% effective in preventing covid-19, based on provisional data from an advanced-stage clinical trial.
“I am pleased to announce that tomorrow we will approve a new contract to obtain another vaccine against covid-19,” said Ursula von der Leyen, adding that the agreement “allows us to buy up to 160 million doses of a vaccine produced by Moderna”.
In August, the Commission, which is the EU Executive and collides with negotiations with vaccine manufacturers on behalf of the bloc’s member countries, said that preliminary talks with Moderna were concluded with the aim of signing a contract for the supply of 80 million doses of your vaccine, with the option to buy another 80 million.
It is the sixth supply agreement that the bloc negotiates with vaccine manufacturers to obtain immunizations against covid-19.